Neuropsicofarmacología - GIC 21/128
Hospital Sierrallana
Torrelavega, EspañaPublications en collaboration avec des chercheurs de Hospital Sierrallana (1)
2019
-
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Translational Psychiatry, Vol. 9, Núm. 1